NTHI vaccine (Biological Mimetics/GlaxoSmithKline)

N/A

Report date: 2025/03/20 10:10:12

Base Information

Drug NameNTHI vaccine (Biological Mimetics/GlaxoSmithKline)
Drug Alias NameNTHI vaccine (Biological Mimetics/GSK)non-typeable hemophilus influenzae vaccine (Biological Mimetics/GSK)non-typeable hemophilus influenzae vaccine (Biological Mimetics/GlaxoSmithKline)
ClassificationVaccines
Mechanisms of ActionBacterial outer membrane proteins modulators
TargetsBacterial outer membrane proteins
Therapy Area/IndicationsOtitis Media
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiological Mimetics
China Registration ClassN/A

Develop Information

Active CompaniesBiological MimeticsGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsOtitis Media
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A